This company analysis examines Altana's market position and future outlook. The profile encompasses global company strategy, portfolio and pipeline analysis, and an assessment of financial performance, with forecasts for key drugs to 2010.
This company analysis examines Altana's market position and future outlook. The profile encompasses global company strategy, portfolio and pipeline analysis, and an assessment of financial performance, with forecasts for key drugs to 2010. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Key reasons to read this report
Benchmark Altana's current and future strategic performance against its key rivals in the pharmaceutical industry
Assess the key drivers and resistors to Altana's growth over the next six years
Explore the development of Altana's major therapeutic franchises and discover the potential of key pipeline products to 2010